v3 Template
S

Supernus Pharmaceuticals Inc.

Biopharmaceutical Boston, MA, USA ~500 employees
Founded
--
Employees (Est.)
~500
25 leaders known
Total Funding
$150.0M
Funding Rounds
1
Last Funding
2023-02-14

About Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals is an award-winning biopharmaceutical company with over 30 years of experience in developing and commercializing products for the treatment of central nervous system (CNS) diseases.

Products & Services

CNS Treatments:Novel products designed to provide important health benefits to patients living with central nervous system (CNS) diseases.
Qelbree™:A recently approved treatment for CNS conditions, with prescribing information and medication guides available.

Specialties

Central Nervous System (CNS) Treatments Research and Development Product Commercialization

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Debt
T: -
FT: Debt 		A: 150000000
MR: -
FA: $150 million
FAN: 150000000 		D: 2023-02-14
FD: 2023-02-14 		1 investors
Debt Latest
2023-02-14
$150.0M
1 investor (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

J

Jack A. Khattar

PRESIDENT AND CHIEF EXECUTIVE OFFICER, DIRECTOR

T

Timothy C. Dec

Senior Vice President and Chief Financial Officer

K

Kevin T. Anderson

COMPLIANCE OFFICER

P

Padmanabh P. Bhatt

Senior Vice President, Chief Scientific Officer, Intellectual Property

J

Jeff Bozick

Senior Vice President of Supply Chain

R

Roman Bradel

Vice President of Regulatory Affairs

View 22 more team members with Pro

Unlock Full Team Directory

Recent News

Supernus Pharmaceuticals Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biopharmaceutical
Company Size
~500 employees (est.)
Locations
Boston, MA, USA
ROCKVILLE, Md., United States
ROCKVILLE, Md. +1 more

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro